September 21, 2022

Applications open for Pietenpol P3 Catalyst Awards; deadline is Oct. 17

The Vanderbilt-Ingram Cancer Center (VICC) announces a funding opportunity to support impactful cancer-related projects at any stage of research (i.e., pilot projects, need for translation, etc.) from any stage faculty member. The goal of this award is to provide funding to support paradigm-shifting, practice-changing, or policy-creating research, named for the former VICC Director, Jennifer Pietenpol, PhD, who challenged investigators with these inspirational goals to drive exceptional research, clinical care, and support for our patients. Both single PI and collaborative project proposals are eligible for an annual award of $50,000 (direct costs). The application and evaluation process will be in two stages. First, applicants will submit a one-page letter of intent (LOI) that contains the Title, Background, Hypothesis, Specific Aims (including the Approach), and a brief paragraph regarding cancer relevance to the “P3”. Top candidates from the LOIs submitted will be invited to a “Shark Tank” style in person/hybrid meeting to provide a five-minute presentation of their work followed by a five-minute question and answer session. Projects will be evaluated and voted upon at the end of this meeting, with awardees notified shortly thereafter. Lay audience members who helped raise philanthropic funds to support this funding will also be invited to participate and vote.

More information available at

Due Date: Oct. 17, 2022